Drug executives grilled in Senate over high prices

Top pharmaceutical executives lined up at a Senate hearing Tuesday and expressed deep compassion for patients suffering from disease. They decried high co-payments that shock consumers at the pharmacy counter. They denounced rebates they pay to insurance companies.

But while they were eager to indict a system they said is badly broken, they declined to commit to lowering their own prices.